P Peris

Summary

Country: Spain

Publications

  1. ncbi Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover
    P Peris
    Department of Rheumatology, IDIBAPS, CIBERehd, Hospital Clinic, University of Barcelona, Spain
    Bone 49:706-9. 2011
  2. ncbi Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease
    L Alvarez
    Service of Clinical Biochemistry, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Bone 29:447-52. 2001
  3. ncbi Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment
    L Alvarez
    Servicio Bioquimica Clinica, Hospital Clinic, C Villarroel 170, 08036 Barcelona, Spain
    Rheumatology (Oxford) 43:869-74. 2004
  4. ncbi Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics
    A Monegal
    Department of Rheumatology, Hospital Clinic, IDIBAPS, University of Barcelona, Spain
    Osteoporos Int 12:484-92. 2001
  5. ncbi Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity
    F Pons
    Department of Nuclear Medicine, University of Barcelona, Spain
    Nucl Med Commun 20:525-8. 1999
  6. ncbi Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy
    P Peris
    Services of Rheumatology, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    Clin Exp Rheumatol 25:206-10. 2007
  7. ncbi Biochemical response to bisphosphonate therapy in pagetic patients with skull involvement
    P Peris
    Department of Rheumatology, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    Calcif Tissue Int 79:22-6. 2006
  8. ncbi Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis
    A Pares
    Liver and Metabolic Bone Diseases Units, Department of Rheumatology, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Hepatology 33:554-60. 2001
  9. ncbi Prostaglandin E2 and bone turnover markers in the evaluation of primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report
    A Martinez-Ferrer
    Rheumatology Service, Hospital Clinic, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Spain
    Clin Rheumatol 28:1229-33. 2009
  10. ncbi Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A
    A Monegal
    Metabolic Bone Diseases Unit, Service of Rheumatology, ICAL, , University of Barcelona, IDIBAPS, Barcelona, Spain
    Calcif Tissue Int 68:83-6. 2001

Collaborators

Detail Information

Publications20

  1. ncbi Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover
    P Peris
    Department of Rheumatology, IDIBAPS, CIBERehd, Hospital Clinic, University of Barcelona, Spain
    Bone 49:706-9. 2011
    ..The relationship between alendronate levels and both bone resorption and time of treatment cessation further indicates a residual effect of this drug in bone, despite treatment discontinuation...
  2. ncbi Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease
    L Alvarez
    Service of Clinical Biochemistry, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Bone 29:447-52. 2001
    ..Data on biological variation are useful for assessing actual changes induced by treatment...
  3. ncbi Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment
    L Alvarez
    Servicio Bioquimica Clinica, Hospital Clinic, C Villarroel 170, 08036 Barcelona, Spain
    Rheumatology (Oxford) 43:869-74. 2004
    ....
  4. ncbi Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics
    A Monegal
    Department of Rheumatology, Hospital Clinic, IDIBAPS, University of Barcelona, Spain
    Osteoporos Int 12:484-92. 2001
    ..Treatment of osteoporosis shortly after liver transplantation may be important in the prevention of bone fractures, particularly in patients with low bone mass...
  5. ncbi Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity
    F Pons
    Department of Nuclear Medicine, University of Barcelona, Spain
    Nucl Med Commun 20:525-8. 1999
    ..In conclusion, quantitative evaluation of bone scintigraphy allows easy and objective assessment of Paget's disease activity and it may be useful in evaluating the effectiveness of therapies...
  6. ncbi Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy
    P Peris
    Services of Rheumatology, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    Clin Exp Rheumatol 25:206-10. 2007
    ..To compare the effects of tiludronate and risedronate on Paget's disease activity assessed by biochemical markers of bone turnover and quantitative bone scintigraphy...
  7. ncbi Biochemical response to bisphosphonate therapy in pagetic patients with skull involvement
    P Peris
    Department of Rheumatology, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    Calcif Tissue Int 79:22-6. 2006
    ..In conclusion, pagetic patients with skull involvement showed a marked increase in bone turnover and a lower response to therapy...
  8. ncbi Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis
    A Pares
    Liver and Metabolic Bone Diseases Units, Department of Rheumatology, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Hepatology 33:554-60. 2001
    ..In conclusion, the COLIA1 but not VDR polymorphism is a genetic marker of peak bone mass in patients with PBC, although the severity of cholestasis is the main factor for osteoporosis since it is associated with the rate of bone loss...
  9. ncbi Prostaglandin E2 and bone turnover markers in the evaluation of primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report
    A Martinez-Ferrer
    Rheumatology Service, Hospital Clinic, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Spain
    Clin Rheumatol 28:1229-33. 2009
    ..In addition, bone turnover markers were useful for monitoring the disease activity; whereas, increased prostaglandin E(2) levels seems to confirm the role of this mediator in the etiopathogenesis of this disorder...
  10. ncbi Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A
    A Monegal
    Metabolic Bone Diseases Unit, Service of Rheumatology, ICAL, , University of Barcelona, IDIBAPS, Barcelona, Spain
    Calcif Tissue Int 68:83-6. 2001
    ..These differences seem to be associated with the lower dose of glucocorticoids used in the FK506 group...
  11. ncbi Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities
    P Peris
    Services of 1Rheumatology, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    Clin Exp Rheumatol 26:986-91. 2008
    ..Therefore, the aim of this study was to analyse the clinical characteristics and bone remodelling abnormalities in premenopausal women with idiopathic osteoporosis...
  12. ncbi Components of biological variation of biochemical markers of bone turnover in Paget's bone disease
    L Alvarez
    Clinical Biochemistry, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Bone 26:571-6. 2000
    ..In addition, serum bAP and PINP seem to be the markers that best reflect a significant change in activity of Paget's disease...
  13. ncbi Aetiology and clinical characteristics of male osteoporosis. Have they changed in the last few years?
    P Peris
    Rheumatology Department, Metabolic Bone Diseases Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Spain
    Clin Exp Rheumatol 26:582-8. 2008
    ....
  14. ncbi Patients with cirrhosis and ascites have false values of bone density: implications for the diagnosis of osteoporosis
    N GuaNabens
    Metabolic Bone Diseases Unit, Service of Rheumatology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
    Osteoporos Int 23:1481-7. 2012
    ..This fact must be considered when assessing bone mass in patients with decompensated cirrhosis...
  15. ncbi Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates
    L Alvarez
    Hospital Clinic, University of Barcelona and Institut d Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
    Arthritis Rheum 48:824-8. 2003
    ....
  16. ncbi Pregnancy associated osteoporosis: the familial effect
    P Peris
    Service of Rheumatology, ICAL, Metabolic Bone Diseases Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Spain
    Clin Exp Rheumatol 20:697-700. 2002
    ....
  17. ncbi [Increase of PTH in post-menopausal osteoporosis]
    D Cerdá
    Unidad de Reumatologia, Servicio de Medicina Interna, Hospital General de Granollers, Barcelona, Espana
    Rev Clin Esp 211:338-43. 2011
    ..This study has aimed to analyze the prevalence and conditions associated to the increased serum PTH levels in postmenopausal women with osteoporosis as well as their clinical characteristics...
  18. ncbi Collagen type Ialpha1 gene polymorphism in idiopathic osteoporosis in men
    P Peris
    Service of Rheumatology, Service of Clinical Biochemistry, Hormonal Laboratory and Service of Nuclear Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Spain
    Rheumatology (Oxford) 39:1222-5. 2000
    ..To analyse the distribution of polymorphism of the collagen type Ialpha1 gene (COL1A1) and its relationship with bone metabolism and bone turnover in men with idiopathic osteoporosis...
  19. ncbi Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome
    J Mundo
    Service of Rheumatology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
    Lupus 15:304-7. 2006
    ..It is important to be aware of this clinical manifestation of APS, especially in these cases where it can be easily overlooked because of corticosteroid therapy...